Published in Cancer Weekly, May 19th, 1997
Theratope is a synthetic cancer vaccine designed to stimulate a patient's own immune system to control the disease with minimal side effects. The partnership capitalizes on the strengths of Chiron Therapeutics in the development, registration, and marketing of biological products for oncology and on Biomira's strengths in immunology, vaccine development, and manufacturing of the Theratope vaccine.
Biomira has primary responsibility for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.